NCI is the leading national institution for high performance computing, and provides world-class high-end services to more than 4,000 Australian researchers from 31 universities, five science agencies and several medical research institutes.
The National Health and Medical Research Council (NHMRC) is Australia’s leading expert body promoting the development and maintenance of public and individual health standards.
NeuroScientific Biopharmaceuticals Ltd is an Australian public company developing novel peptide-based pharmaceutical products that target a number of neurological disorders that have high unmet medical needs.
NextMed Capital's mission is to nurture the seeds of the next generation of medical innovation. The company was founded in 2016 with the goal of becoming Australia's leading very early stage innovation and medical technology investor. NextMed Capital can invest in projects as early as the pre-clinical phase and adds significant value to its investments through leveraging the combined commercial, entrepreneurial, project management, financing, business planning and academic skills of its experienced management team.
Formed in October 2013, NIESM is a Melbourne-based Australian company that delivers clinician support tools focused around wearable technologies and an enterprise software platform to provide optimal health outcomes for patients with epilepsy. NIESM has put together a global team with world leaders in technology, clinical and business capabilities and they are committed to helping patients become seizure free.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies.
Novita Healthcare is an emerging health sector technology company encompassing the current businesses of TALI Health and Newly. The TALI system uses proprietary software algorithms to monitor and assist in the treatment of cognitive problems such as attention difficulties in early childhood.
NSW Health’s Office for Health & Medical Research is focused on providing researchers, clinicians, managers and policy makers with the tools they need to translate research into innovative policy and practice to create healthier communities and deliver better patient care in NSW.
Nucleus Network is a leading early phase clinical research organisation in Australia, providing an expedited regulatory pathway, the CTN scheme, for the initiation of first-in-human clinical trials without the need for filing an IND.
As a small start-up company, born of the digital age, OMX-Solutions have the flexibility of providing custom devices, which can easily and rapidly be delivered through the use of CAD-CAM technology. With our experience in digital design, and our successful use of devices developed by advanced additive and subtractive manufacturing methods, we have the capability of producing an unlimited range of medical devices that is only limited by our imagination.
The Oral Health CRC seeks to reduce the economic and social burden of oral diseases on Australians. They bring together world-class scientific and clinical research teams with Australian manufacturers and established global marketers and distributors.
Orthocell is a regenerative medicine company focused on regenerating mobility for patients by developing products for the repair of a variety of tendon, cartilage and soft tissue injuries.
Osteon Medical is an Australian-owned company that designs and manufactures a specialised range of dental and facial implant prosthetic products. All products are digitally created and precision milled for dental and Maxillofacial professionals. Osteon's implant frameworks are designed specific to each patient with the aim to restore or replace the function of patient bone, teeth or soft tissues in affected areas, restore normal function and resemble natural aesthetics.
Pacific Analytics are an analytics company building analysis tools, databases pipelines and software specialising in precision medicine. Its current clients include the Cerebral Palsy Research Foundation and Iggy Get out! a motor neurone disease research non-profit organisation.
Pattens was started by the first Group Financial Controller of Cochlear Ltd. Surprisingly, Cochlear would not exist today if not for government grants secured.
With over 20 years’ experience in Australia's & New Zealand's Medical Devices and Biotech industries, Paul L Clark and Associates offers an expansive range of Regulatory, Clinical, Quality Management & Commercial services for medical device companies marketing their products. They cover the Australian Register of Therapeutic Goods (ARTG); sponsorship for international companies selling into Australia; liaison with the Therapeutic Goods Administration (TGA); and commercial services.
Peninsula Health is the major health care provider serving the metropolitan and regional areas on Victoria’s Mornington Peninsula. They provide a wide range of services from obstetrics to aged care, rehabilitation, emergency and intensive care, oncology, psychiatric services and Hospital in the Home (HITH).
The Perron Institute for Translational and Neurological Science, formerly the Western Australian Neuroscience Research Institute, is Western Australia's longest established medical research institute and has facilities within the QEII Medical Centre and Murdoch University.
The Perth Blood Institute (PBI) is a medical research institute specialising in blood disorders, including haemophilia, deep vein thrombosis, leukaemia, myeloma and lymphoma.
The Peter MacCallum Cancer Centre is one of the world’s leading cancer research, education and treatment centres and is Australia’s only public hospital solely dedicated to caring for people affected by cancer. The Centre has over 2,500 staff, including more than 580 laboratory and clinical researchers, all focused on providing better treatments, better care and potential cures for cancer.